Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institution

Annals of Oncology

Volumn 9, Issue 2, 1998, Pages 167-172

  Esteve, J ^a,b   Villamor, N ^b   Colomer, D ^b   Bosch, F ^a   Lopez Guillermo A ^a   Rovira, M ^a   Urbano Ispizua, A ^a   Sierra, J ^a   Carreras, E ^a   Montserrat, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Chronic lymphocytic leukemia; Hematopoietic stem cell transplantation; Minimal residual disease; Molecular remissions

Indexed keywords

ADULT; AGED; ARTICLE; AUTOGRAFT; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CYTOFLUOROMETRY; FEMALE; HEMATOPOIETIC CELL; HIGH RISK POPULATION; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; STEM CELL; STEM CELL TRANSPLANTATION;

ADULT; CYCLOPHOSPHAMIDE; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 6844260550     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008266505896     Document Type: Article

References (25)

1. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052-7.
2. Montserrat E, Rozman C. Chronic lymphocytic leukemia: Present status. Ann Oncol 1995; 6: 219-35.
3. O'Brien S, del Giglio A, Keating M. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 1995; 85: 307-18.
4. Montserrat E, Gomis F, Vallespi T et al. Presenting features and prognosis of chronic lymphocytic leukemia in younger patients. Blood 1991; 78: 1545-51.
5. Dhodapkar M, Tefferi A, Su J et al. Prognostic factors and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): A single institution study. Leukemia 1993; 8: 1232-5.
6. Montserrat E, Bosch F, Jarque I et al. Criteria to treat younger CLL patients with experimental therapies: A proposal based on the study of 179 patients under the age of 50 (abstract accepted for the 1997 ASH meeting).
7. Montserrat E, Gale RP, Rozman C. Bone marrow transplants for chronic lymphocytic leukemia. Leukemia 1992; 6: 619-622.
8. Rabinowe S, Soiffer RJ, Gribben JG et al. Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1366-76.
9. Khouri IF, Keating M, Vriesendorp HM et al. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: Preliminary results. J Clin Oncol 1994; 12: 748-58.
10. Michallet M, Archimbaud E, Bandini G et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. Ann Intern Med 1996; 124: 311-5.
11. Dreger P, Viehlman K, von Neuhoff N et al. Treatment of chronic lymphocytic leukemia in patients of young age: The curative potential of stem cell transplantation. Bone Marrow Transplant 1996; 17(Supp 1): S146 (Abstr).
12. Dreger P, Schmitz N. The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia. Leukemia 1997; 11 (Suppl 2): S42-S5.
13. International Workshop on Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia: Recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989; 110: 236-8.
14. Cheson BD, Benett JM, Grever M et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-7.
15. Michallet M, Archimbaud E, Rowlings PA et al. Hemopoietic stem-cell transplant for chronic lymphocytic leukemia. Bone Marrow Transplant 1996; 17 (Suppl 1): S3.
16. Jarque I, Palau J, Sanz GF et al. Delayed complete response after allogeneic bone marrow transplantation in chronic lymphocytic leukemia. Blood 1993; 82: 1036-7 (Letter).
17. Urbano-Ispizua A, Rozman C, Martinez C et al. Rapid engraftment without significant graft-versus-host disease after allogeneic bone marrow transplanation of CD34+ selected cells from peripheral blood. Blood 1997; 89: 3967-73.
18. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531-6.
19. Zomas A, Mehta J, Powels R et al. Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 1994; 14: 799-803.
20. Mehta J, Powels R, Singhal S et al. Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or bone marrow transplantation. Leuk Lymph 1997; 26: 83-8.
21. Gahn B, Schäfer C, Neef J et al. Detection of trisomy 12 and Rbdeletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia. Blood 1997; 89: 4275-81.
22. Mehta J, Powels R, Singhal S et al. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: Possible role of graftversus-leukemia. Bone Marrow Transplant 1996; 17: 371-5.
23. Rondón G, Giralt S, Huh Y et al. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 1996; 18: 669-72.
24. DeMagathaes M, Donnenberg A, Hammert L et al. Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia. Bone Marrow Transplant 1997; 20: 175-7.
25. Provan D, Bartlett L, Zwicky C et al. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 1996; 88: 2228-35.